Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 08:00 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

Lund, Sweden, September 7, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the company is scheduled to present at the...
September 07, 2016 08:00 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive presenterar på Rodman & Renshaw 18th Annual Global Investment Conference

Lund, den 7 september, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att företaget kommer att presenteras på...
August 30, 2016 05:32 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive announces that the clinical study CiPRICS will be presented at the Swedish Thorax meeting in October 2016

Lund, Sweden, August 30, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the clinical study CiPRICS will be presented...
August 30, 2016 05:32 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive meddelar att den kliniska studien CiPRICS presenteras på Svenska Thorax-mötet i oktober 2016

Lund, den 30 augusti, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att den kliniska studien CiPRICS kommer att...
August 24, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVives operative chef Jan Nilsson lämnar bolaget

Lund, den 24 augusti, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att dess operative chef, Jan Nilsson lämnar...
August 24, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company

Lund, Sweden, August 24, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that its Chief Operating Officer, Jan Nilsson...
August 18, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical - Interim report January-June 2016

Business operations Important events April-June 2016 · Fully subscribed rights issue amounting to approximately SEK 77.3 million after issue expenses · A preclinical TBI program initiated...
August 18, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical - Delårsrapport januari-juni 2016

Verksamheten Väsentliga händelser april-juni 2016 · Företrädesemissionen fulltecknades och tillförde bolaget 77,3 miljoner kronor efter emissionskostnader · Ett prekliniskt TBI-program inleddes i...
August 15, 2016 07:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive completes 10 percent acquisition of Isomerase Therapeutics

Lund, Sweden, August 15, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the second step in the previously announced...
August 15, 2016 07:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive fullföljer 10 procents delförvärv av Isomerase Therapeutics

Lund, den 15 augusti, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att andra delen av det sedan tidigare annonserade...